Azacitidine, Venetoclax, and Pevonedistat in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

Clinical trial NCT03862157 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03862157
Sponsor: M.D. Anderson Cancer Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative Chronic Eosinophilic Leukemia, Not Otherwise Specified Chronic Myelomonocytic Leukemia Chronic Neutrophilic Leukemia Essential Thrombocythemia Myelodysplastic Syndrome Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable Myeloid Neoplasm Myeloproliferative Neoplasm Myeloproliferative Neoplasm, Unclassifiable

Start date: 2019-02-27
Primary completion: 2027-01-31
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.